{"id":"https://openalex.org/W7146862333","doi":null,"title":"Progress of Therapeutic Antibodies in the Treatment of Patients with Multiple Myeloma and Possible Impacts of Antibodies on the Evaluation of Response to the Treatment","display_name":"Progress of Therapeutic Antibodies in the Treatment of Patients with Multiple Myeloma and Possible Impacts of Antibodies on the Evaluation of Response to the Treatment","publication_year":2024,"publication_date":"2024-12-25","ids":{"openalex":"https://openalex.org/W7146862333"},"language":"ja","primary_location":{"id":"pmh:oai:irdb.nii.ac.jp:01433:0006563880","doi":null,"is_oa":true,"landing_page_url":"https://dmu.repo.nii.ac.jp/records/2000491","pdf_url":"https://dmu.repo.nii.ac.jp/record/2000491/files/DKMJ-3-4-1.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dokkyo Medical Journal","raw_type":"journal article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://dmu.repo.nii.ac.jp/record/2000491/files/DKMJ-3-4-1.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021687301","display_name":"Yoichi Imai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Imai, Yoichi","raw_affiliation_strings":["Department of Hematology and Oncology , Dokkyo Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108755741","display_name":"Tomoyuki Handa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Handa, Tomoyuki","raw_affiliation_strings":["Department of Hematology and Oncology , Dokkyo Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University","institution_ids":["https://openalex.org/I78274823"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110125362","display_name":"Kinuko Mitani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78274823","display_name":"Dokkyo Medical University","ror":"https://ror.org/05k27ay38","country_code":"JP","type":"education","lineage":["https://openalex.org/I78274823"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitani, Kinuko","raw_affiliation_strings":["Department of Hematology and Oncology , Dokkyo Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology , Dokkyo Medical University","institution_ids":["https://openalex.org/I78274823"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I78274823"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"4","first_page":"245","last_page":"252"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.9750000238418579},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/isatuximab","display_name":"isatuximab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/elotuzumab","display_name":"elotuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.9900000095367432},{"id":"https://openalex.org/keywords/slamf7","display_name":"SLAMF7","score":0.996999979019165},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8339999914169312},{"id":"https://openalex.org/keywords/immunofixation","display_name":"immunofixation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/igg-kappa","display_name":"IgG kappa","score":0.5019999742507935},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.6290000081062317},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.7099999785423279},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8271999955177307},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6825000047683716},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6547999978065491},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5249999761581421},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4253000020980835},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.4074999988079071},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3447999954223633},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.32359999418258667},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.3172999918460846},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3133000135421753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3102000057697296},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.296099990606308},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2892000079154968},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.2865000069141388},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.28189998865127563},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C3017456870","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Specific antibody","level":3,"score":0.2599000036716461}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:irdb.nii.ac.jp:01433:0006563880","doi":null,"is_oa":true,"landing_page_url":"https://dmu.repo.nii.ac.jp/records/2000491","pdf_url":"https://dmu.repo.nii.ac.jp/record/2000491/files/DKMJ-3-4-1.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dokkyo Medical Journal","raw_type":"journal article"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01433:0006563880","doi":null,"is_oa":true,"landing_page_url":"https://dmu.repo.nii.ac.jp/records/2000491","pdf_url":"https://dmu.repo.nii.ac.jp/record/2000491/files/DKMJ-3-4-1.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dokkyo Medical Journal","raw_type":"journal article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7146862333.pdf","grobid_xml":"https://content.openalex.org/works/W7146862333.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W3027520213","https://openalex.org/W3037179214"],"related_works":["https://openalex.org/W2182681254","https://openalex.org/W4302763162","https://openalex.org/W3118702963","https://openalex.org/W3092324321","https://openalex.org/W4311663966","https://openalex.org/W3167862879","https://openalex.org/W185188655","https://openalex.org/W2896715321","https://openalex.org/W2558137839","https://openalex.org/W2898306454"],"abstract_inverted_index":{"Multiple":[0],"myeloma":[1,74,122,137],"(MM)":[2],"is":[3,113,130,161],"an":[4],"incurable":[5],"hematological":[6],"malignancy.":[7],"Introduction":[8],"of":[9,79,89,99,110,115,121,128,146,165,185,203,235,241,247],"autologous":[10],"stem":[11],"cell":[12],"transplantation,":[13],"as":[14,16,64,83],"well":[15],"proteasome":[17],"inhibitors":[18],"and":[19,36,54,87,171,178,219,238],"immunomodulatory":[20],"drugs":[21],"(IMiDs)":[22],"has":[23],"improved":[24],"the":[25,62,77,97,116,144,183,189,195,201,245,250],"treatment":[26,38,109,141,251],"results.":[27],"However,":[28],"many":[29],"patients":[30,42],"develop":[31],"resistance":[32],"to":[33,102,132,157,167,194,249],"existing":[34],"therapies,":[35],"novel":[37],"strategies":[39],"for":[40,66,119,163,210,226],"these":[41,242],"must":[43],"be":[44,253],"established.":[45],"Therapeutic":[46],"antibodies":[47,69,101,205,215,237,243],"including":[48],"daratumumab":[49,129,140,170],"or":[50],"isatuximab":[51],"targeting":[52,56],"CD38":[53,112,134],"elotuzumab":[55,172],"SLAMF7":[57],"have":[58,228],"been":[59,229],"introduced":[60],"in":[61,108,124,136],"clinic":[63],"immunotherapies":[65],"MM.":[67,111],"These":[68],"exert":[70],"cytotoxic":[71],"effects":[72],"on":[73,106,206,244],"cells":[75,81,86,123],"through":[76],"activation":[78],"effector":[80],"such":[82],"natural":[84],"killer":[85],"induction":[88],"phagocytosis":[90],"by":[91,151],"macrophages.":[92],"The":[93,126],"recent":[94],"studies":[95],"suggest":[96],"possibility":[98],"therapeutic":[100,204,236],"bring":[103],"about":[104],"influence":[105,202],"testing":[107],"one":[114],"antigens":[117],"used":[118],"detection":[120],"flowcytometry.":[125],"use":[127],"supposed":[131],"downregulate":[133],"expression":[135],"cells.":[138],"Thus,":[139],"may":[142,181],"affect":[143,182],"evaluation":[145,164,184,246],"minimal":[147],"residual":[148],"disease":[149],"(MRD)":[150],"flow":[152],"cytometry.":[153],"Immunofixation":[154],"electrophoresis":[155,187,222],"(IFE)":[156],"detect":[158],"monoclonal":[159],"protein":[160,192],"essential":[162],"response":[166,248],"treatment.":[168],"Both":[169],"are":[173],"derived":[174],"from":[175,216],"human":[176],"IgG-k":[177,197],"their":[179],"administration":[180],"immunofixation":[186,221],"if":[188],"tumor-derived":[190],"M":[191],"belongs":[193],"same":[196],"subclass.":[198],"To":[199],"overcome":[200],"testing,":[207],"a":[208],"method":[209],"detecting":[211],"MRD":[212],"using":[213],"different":[214],"conventional":[217],"ones":[218],"daratumumab-specific":[220],"reflex":[223],"assay":[224],"(DIRA)":[225],"IFE":[227],"introduced.":[230],"In":[231],"this":[232],"review,":[233],"progress":[234],"possible":[239],"impacts":[240],"will":[252],"discussed.":[254]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-04-01T00:00:00"}